- Home
- LUCD vs AMTX Comparison
LUCD vs AMTX Comparison
Compare LUCD & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- AMTX
- Stock Information
- Founded
- LUCD 2018
- AMTX 2005
- Country
- LUCD United States
- AMTX United States
- Employees
- LUCD N/A
- AMTX N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AMTX Major Chemicals
- Sector
- LUCD Health Care
- AMTX Industrials
- Exchange
- LUCD Nasdaq
- AMTX Nasdaq
- Market Cap
- LUCD 140.7M
- AMTX 125.1M
- IPO Year
- LUCD 2021
- AMTX N/A
- Fundamental
- Price
- LUCD $1.16
- AMTX $2.49
- Analyst Decision
- LUCD Strong Buy
- AMTX Strong Buy
- Analyst Count
- LUCD 4
- AMTX 4
- Target Price
- LUCD $3.94
- AMTX $13.63
- AVG Volume (30 Days)
- LUCD 1.5M
- AMTX 1.3M
- Earning Date
- LUCD 08-11-2025
- AMTX 07-31-2025
- Dividend Yield
- LUCD N/A
- AMTX N/A
- EPS Growth
- LUCD N/A
- AMTX N/A
- EPS
- LUCD N/A
- AMTX N/A
- Revenue
- LUCD $4,173,000.00
- AMTX $237,892,000.00
- Revenue This Year
- LUCD $91.46
- AMTX $27.78
- Revenue Next Year
- LUCD $213.42
- AMTX $91.59
- P/E Ratio
- LUCD N/A
- AMTX N/A
- Revenue Growth
- LUCD 39.89
- AMTX N/A
- 52 Week Low
- LUCD $0.72
- AMTX $1.22
- 52 Week High
- LUCD $1.80
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- LUCD 42.03
- AMTX 71.27
- Support Level
- LUCD $1.13
- AMTX $2.03
- Resistance Level
- LUCD $1.21
- AMTX $2.39
- Average True Range (ATR)
- LUCD 0.07
- AMTX 0.17
- MACD
- LUCD -0.01
- AMTX 0.03
- Stochastic Oscillator
- LUCD 28.57
- AMTX 97.12
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.